Clinical Trial Update: A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients

View source ↗

Summary

A clinical trial update examining L5 as a risk factor for cardiovascular disease in patients with chronic kidney disease and those on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Hyperlipidemia

Snippet

Sponsor: China Medical University Hospital | Conditions: Cardiovascular Disease, Chronic Kidney Disease Patients | Status: UNKNOWN